SL 0101-1 attenuates the activity of kinases involved in cell growth, survival, and proliferation, which can be utilized to inhibit tumor progression. It targets RSK1.
Molecular Weight
516.45
Molecular Formula
C25H24O12
Targets
RSK1
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
SL 0101-1 can be utilized to investigate its inhibitory effects on RSK and its potential implications in cancer therapy.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
